Post Marketing Observational Study of Reformulated BeneFIX

CompletedOBSERVATIONAL
Enrollment

58

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Hemophilia B
Interventions
OTHER

No intervention

As it is a non interventional study, patient receives his usual treatment (BeneFIX) as determined by the physician

Trial Locations (17)

13385

Pfizer Investigational Site, Marseille

14033

Pfizer Investigational Site, Caen

21070

Pfizer Investigational Site, Dijon

37044

Pfizer Investigational Site, Tours

42277

Pfizer Investigational Site, Saint-Priest-en-Jarez

44093

Pfizer Investigational Site, Nantes

54511

Pfizer Investigational Site, Vandœuvre-lès-Nancy

63003

Pfizer Investigational Site, Clermont-Ferrand

69003

Pfizer Investigational Site, Lyon

73011

Pfizer Investigational Site, Chamberry

75014

Pfizer Investigational Site, Paris

76031

Pfizer Investigational Site, Rouen

78157

Pfizer Investigational Site, Le Chesnay

94275

Pfizer Investigational Site, leKremlin-Bicetre

95160

Pfizer Investigational Site, Montmorency

34 34295

Pfizer Investigational Site, Montpellier

F-75015

Pfizer Investigational Site, Paris

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY